AML clinical trials: early stage vs. relapse/refractory patients - 101793

Spotlight
Video

AML clinical trials: early stage vs. relapse/refractory patients

VJHemOnc has 872 videos Subscribe Here

Loading........
Description: Cinical trials for acute myeloid leukemia (AML) typically only include relapsed/refractory patients, rather than patients at an earlier stages of the disease. Speaking from the International Conference on Acute Myeloid Leukemia 2017, Estoril, Portugal by the European School of Hematology (ESH), Marion Subklewe, MD, of the University of Munich, Munich, Germany, explains the downsides of this, but highlights the reasons why this occurs.
Shared By : VJHemOnc
Posted on : 11/28/17
Added : 2 months ago



Recommended

Nothing found.

More From VJHemOnc

Nothing found.